Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;49(11):1289-1291.
doi: 10.3899/jrheum.220007. Epub 2022 Aug 15.

Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate

Courtney McCracken  1 , Jessica G Shantha  2 , Steven Yeh  3 , Kirsten Jenkins  4 , Kelly A Rouster-Stevens  4 , Scott R Lambert  5 , Sampath Prahalad  1   4   6 , Carolyn Drews-Botsch  7 , Sheila T Angeles-Han  8
Affiliations

Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate

Courtney McCracken et al. J Rheumatol. 2022 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

SY is a consultant for Santen and Clearside Biomedical, unrelated to this study. KARS is a consultant for Accordant, unrelated to this study. SP serves on the Macrophage Activation Syndrome Adjudication Committee for Novartis and is a Doximity Op-Med Fellow for 2021–22, unrelated to this study. The remaining authors declare no conflicts of interest relevant to this article.

Figures

Figure.
Figure.
Kaplan-Meier (KM) estimates for time to relapse on methotrexate.
See this image and copyright information in PMC

References

    1. Lerman MA, Lewen MD, Kempen JH, Mills MD. Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 2015;160:193–200. - PMC - PubMed
    1. Simonini G, Bracaglia C, Cattalini M, et al. Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis. J Rheumatol 2017;44:822–6. - PubMed
    1. Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH. Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol 2011;151:217–22. - PubMed
    1. Saboo US, Metzinger JL, Radwan A, et al. Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. J AAPOS 2013;17:460–4. - PubMed
    1. Acharya NR, Ebert CD, Kelly NK, et al. Discontinuing adalimumab in patients with controlled juvenile idiopathic arthritis-associated uveitis (ADJUST-Adalimumab in Juvenile Idiopathic Arthritis-associated Uveitis Stopping Trial): study protocol for a randomised controlled trial. Trials 2020;21:887. - PMC - PubMed

Publication types

LinkOut - more resources